Ariel Effrigan

Uh, part of the, some of the commercial agreements are starting pilot mode that automatically converts to commercial contract.

You know, there's in healthcare, there's a level of kind of efficacy validation, right?

You know, if we screw up, it's not like your food doesn't get to you, you know, someone dies.

Right.

So we need to be pretty sure.

So there's a step of clinical validation, uh, which is kind of part of the pilot.

And then that goes into commercial terms.

About six.

Within each one of those, there could be 10 different customers.

And these are six kind of parent companies that we contract with, but...

Each one has many different... For instance, one is a health system that they have about 90 hospitals or something like that.

Actually, our first customer was an academic medical center in Israel called Hadassah that we did a clinical study with.

That was really the first, and that came from one of our co-founders.

She is a PharmD by training, and she was the head of pharmacy services for the second largest HMO in the world.

as well as the head and founder of the Pharmacovigilance Department, the Ministry of Health, and also ran her own private clinics.

So she's a pretty well-known pharmacist in the space and drug safety expert.

And so really because of her and her research, we were able to get some really early interest in this platform.

I didn't join as a co-founder.

I just joined the kind of founding team.

So it was the sixth employee, I think.